$1.20
0.01[0.84%]
At close: May 16
$1.20
0[0.00%]
After Hours: 7:34PM EDT
Augmedix
(NASDAQ:AUGX)Augmedix Stock (NASDAQ:AUGX), Analyst Ratings, Price Targets, Predictions
Augmedix Inc has a consensus price target of $4.14, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from Lake Street, Maxim Group, and Evercore ISI Group on May 14, 2024, May 14, 2024, and April 9, 2024. With an average price target of $2.83 between Lake Street, Maxim Group, and Evercore ISI Group, there's an implied 136.11% upside for Augmedix Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Lake Street
Maxim Group
Evercore ISI Group
B. Riley Securities
Benchmark
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Augmedix
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | Buy Now | 191.67% | Lake Street | Brooks O'Neil | $8 → $3.5 | Maintains | Buy | Get Alert |
| 05/14/2024 | Buy Now | — | Maxim Group | Allen Klee | — | Downgrade | Buy → Hold | Get Alert |
| 04/09/2024 | Buy Now | 316.67% | Evercore ISI Group | Elizabeth Anderson | $4.5 → $5 | Upgrade | In-Line → Outperform | Get Alert |
| 04/03/2024 | Buy Now | 358.33% | B. Riley Securities | Neil Chatterji | → $5.5 | Reinstates | → Buy | Get Alert |
| 03/19/2024 | Buy Now | 275% | Evercore ISI Group | Elizabeth Anderson | $6.5 → $4.5 | Maintains | In-Line | Get Alert |
| 03/19/2024 | Buy Now | 316.67% | Maxim Group | Allen Klee | $6.5 → $5 | Maintains | Buy | Get Alert |
| 12/15/2023 | Buy Now | 400% | Evercore ISI Group | Elizabeth Anderson | → $6 | Initiates | → In-Line | Get Alert |
| 05/16/2023 | Buy Now | 400% | Benchmark | Bill Sutherland | → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2023 | Buy Now | 358.33% | B. Riley Securities | Neil Chatterji | $5 → $5.5 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | 566.67% | Maxim Group | Allen Klee | $5 → $8 | Maintains | Buy | Get Alert |
| 04/21/2023 | Buy Now | 400% | Benchmark | Bill Sutherland | $5 → $6 | Maintains | Buy | Get Alert |
| 04/20/2023 | Buy Now | 316.67% | B. Riley Securities | Neil Chatterji | $4 → $5 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 316.67% | Benchmark | Bill Sutherland | → $5 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | Buy Now | 316.67% | Maxim Group | Allen Klee | $4 → $5 | Maintains | Buy | Get Alert |
| 03/07/2022 | Buy Now | 400% | Lake Street | Brooks O'Neil | → $6 | Initiates | → Buy | Get Alert |
| 01/21/2022 | Buy Now | 400% | Maxim Group | Allen Klee | → $6 | Initiates | → Buy | Get Alert |
| 11/01/2021 | Buy Now | 400% | Benchmark | Bill Sutherland | — | Initiates | → Buy | Get Alert |
| 11/01/2021 | Buy Now | — | William Blair | Ryan Daniels | — | Initiates | → Outperform | Get Alert |
| 06/10/2021 | Buy Now | 650% | B. Riley Securities | Andrew D'Silva | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Augmedix (AUGX)?
The latest price target for Augmedix (NASDAQ: AUGX) was reported by Lake Street on May 14, 2024. The analyst firm set a price target for $3.50 expecting AUGX to rise to within 12 months (a possible 191.67% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Augmedix (AUGX)?
The latest analyst rating for Augmedix (NASDAQ: AUGX) was provided by Lake Street, and Augmedix maintained their buy rating.
When was the last upgrade for Augmedix (AUGX)?
The last upgrade for Augmedix Inc happened on April 9, 2024 when Evercore ISI Group raised their price target to $5. Evercore ISI Group previously had an in-line for Augmedix Inc.
When was the last downgrade for Augmedix (AUGX)?
The last downgrade for Augmedix Inc happened on May 14, 2024 when Maxim Group changed their price target from N/A to N/A for Augmedix Inc.
When is the next analyst rating going to be posted or updated for Augmedix (AUGX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Augmedix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Augmedix was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
Is the Analyst Rating Augmedix (AUGX) correct?
While ratings are subjective and will change, the latest Augmedix (AUGX) rating was a maintained with a price target of $8.00 to $3.50. The current price Augmedix (AUGX) is trading at is $1.20, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.